Dr. Franklin R. Witney
Chairman of the Board
Dr. Franklin R. Witney, also known as Frank, Ph.D., has been an Operating Partner at Ampersand Capital Partners since 2016. He most recently served as President and Chief Executive Officer of Affymetrix, Inc. (now part of Thermo Fisher Scientific), which specializes in microarray technology and cellular analysis. Previously, Dr. Witney was President and Chief Executive Officer of Dionex Corp., a market leading ion and high-performance liquid chromatography company. Prior to that, Dr. Witney first joined Affymetrix when it acquired Panomics Inc., a quantitative biology company, which he led as President and Chief Executive Officer. He previously held executive roles at Bio-Rad, Packard Bioscience and PerkinElmer. Dr. Witney was a post-doctoral fellow at the National Institutes of Health from 1980 to 1983 and holds a doctorate in molecular and cell biology from Indiana University. Among other corporate Board positions, Dr. Witney is also currently Chairman of the Board for Gyros Protein Technologies AB and holds Board positions for PerkinElmer, Cerus Corporation, RareCyte, Nexcelom, GenapSys (Executive Board Member), and Canopy Biosciences (Chairman). He has authored more than 15 papers on molecular biology and biochemistry and holds seven patents.